PDT Partners’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
226,991
-11,078
| -5% | -$89.6K | 0.1% | 319 |
|
|
2025
Q1 | $2M | Buy |
238,069
+158,900
| +201% | +$1.33M | 0.14% | 252 |
|
|
2024
Q4 | $627K | Buy |
+79,169
| New | +$627K | 0.06% | 432 |
|
|
2023
Q4 | – | Sell |
-88,008
| Closed | -$371K | – | 537 |
|
|
2023
Q3 | $371K | Buy |
+88,008
| New | +$371K | 0.05% | 449 |
|
|
2022
Q4 | – | Sell |
-68,449
| Closed | -$138K | – | 624 |
|
|
2022
Q3 | $138K | Sell |
68,449
-61,681
| -47% | -$124K | 0.02% | 762 |
|
|
2022
Q2 | $414K | Sell |
130,130
-6,686
| -5% | -$21.3K | 0.04% | 645 |
|
|
2022
Q1 | $571K | Buy |
136,816
+26,250
| +24% | +$110K | 0.05% | 540 |
|
|
2021
Q4 | $530K | Buy |
+110,566
| New | +$530K | 0.04% | 512 |
|
|
2021
Q3 | – | Sell |
-36,020
| Closed | -$184K | – | 765 |
|
|
2021
Q2 | $184K | Buy |
+36,020
| New | +$184K | 0.01% | 717 |
|